These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35861278)

  • 41. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
    Breza J; Breza J
    Bratisl Lek Listy; 2018; 119(2):120-125. PubMed ID: 29455549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple endocrine neoplasia 2B: delayed presentation, rapid diagnosis.
    Balachandran K; Kamalanathan S; Gopalakrishnan S; Murugananadham K
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs รก Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.
    Kraimps JL; Denizot A; Carnaille B; Henry JF; Proye C; Bacourt F; Sarfati E; Dupond JL; Maes B; Travagli JP; Boneu A; Roger P; Houdent C; Barbier J; Modigliani E
    World J Surg; 1996 Sep; 20(7):808-12; discussion 812-3. PubMed ID: 8678955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unusual clinical manifestation of pheochromocytoma in a MEN2A patient.
    Guerrieri M; Filipponi S; Arnaldi G; Giovagnetti M; Lezoche E; Mantero F; Taccaliti A
    J Endocrinol Invest; 2002 Jan; 25(1):53-7. PubMed ID: 11883866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adrenal malignant melanoma masquerading as a pheochromocytoma in a patient with a history of a multifocal papillary and medullary thyroid carcinoma.
    Barmpari ME; Savvidis C; Dede AD; Markogiannakis H; Dikoglou C; Xekouki P; Stratakis CA; Andreas M; Malaktari-Skarantavou S
    Hormones (Athens); 2016 Apr; 15(2):283-290. PubMed ID: 27376430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type IIA.
    Porpiglia F; Destefanis P; Bovio S; Allasino B; Orlandi F; Fontana D; Angeli A; Terzolo M
    Horm Res; 2002; 57(5-6):197-9. PubMed ID: 12053093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
    Pati M; Sperti P; Magiar AV; Bonifacio V
    Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MEN2A syndrome presenting as medullary thyroid cancer metastasizing into the pheochromocytoma.
    Tuo YL; Xie J
    Asian J Surg; 2022 May; 45(5):1143-1144. PubMed ID: 35279319
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families.
    Wang YP; Li FP; Wang HH; Fang XD; Zhu ZS; Chen YL; Qi XP
    Endocr Metab Immune Disord Drug Targets; 2022; 22(3):339-347. PubMed ID: 34445950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Multiple endocrine neoplasia syndromes. Type 2].
    Juodele L; Juozaityte E; Zindzius A; Pundzius J
    Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrence of phaeochromocytoma in pregnancy in a patient with multiple endocrine neoplasia 2A: a case report and review of literature.
    Tingi E; Kyriacou A; Verghese L
    Gynecol Endocrinol; 2016 Nov; 32(11):875-880. PubMed ID: 27808580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes.
    Lairmore TC; Ball DW; Baylin SB; Wells SA
    Ann Surg; 1993 Jun; 217(6):595-601; discussion 601-3. PubMed ID: 8099474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rare and aggressive metastatic pheochromocytoma recurrence in a patient with MEN 2A syndrome.
    Hernandez EF; Nicodemus NA
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38307622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case report: bilateral adrenal pheochromocytoma.
    Townsend RR; McGinnis PA; Tuan WM; Thrasher K
    Am J Med Sci; 1994 Aug; 308(2):123-5. PubMed ID: 8042654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Surgical aspects of multiple endocrine neoplasia type 2].
    Lorenz K; Satiroglu I
    Ther Umsch; 2020 Nov; 77(9):457-465. PubMed ID: 33146093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unique moments in time: what patients teach us.
    van Heerden JA
    Surgery; 2012 Jun; 151(6):898. PubMed ID: 22386710
    [No Abstract]   [Full Text] [Related]  

  • 58. Multiple endocrine neoplasia type 2A syndrome (MEN2A) and usefulness of 68Ga-DOTATATE PET/CT in this syndrome.
    Tuzcu SA; Pekkolay Z
    Ann Ital Chir; 2019; 90():497-503. PubMed ID: 30837349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sipple syndrome (bilateral phaeochromocytoma medullary C-cell carcinoma of the thyroid gland) with exceptionally prolonged clinical course].
    Kovarik J; Silberbauer K; Woloszczuk W; Krisch K; Geyer G
    Wien Klin Wochenschr; 1982 Jun; 94(13):340-5. PubMed ID: 6127842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening.
    Rowland KJ; Chernock RD; Moley JF
    J Surg Oncol; 2013 Sep; 108(4):203-6. PubMed ID: 23868299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.